Having demonstrated that HDAC3 inhibition significantly down-regulates pro-inflammatory cytokine expression in BMSCs, we aimed to elucidate the molecular mechanisms by which HDAC3 in BMSCs regulates the hyperinflammatory environment in AML. This evidence concerns the gene HDAC3 and acute myeloid leukemia.